Foundation, and Hoshi General Hospital. S. J. Turner is employed by Novartis. S. Massaro is employed by, has received travel support from, and has stock/stock options in Novartis. S. Clark has received a service agreement from Massachusetts General Hospital for participation in a multicenter study. C. A. Camargo has received research support from Novartis and Teva and has consultant arrangements with GlaxoSmithKline, Merck, Novartis, and Teva. The rest of the authors declare that they have no relevant conflicts of interest.
Asthma remains an important public health burden in the United States. Asthma prevalence is at historically high levels, affecting 26 million persons in 2010. 1 There are 1.8 million emergency department (ED) visits and 440,000 hospitalizations for asthma, 1 with an estimated economic burden of $56 billion annually. 2 In this context the US government has identified improving asthma care as a national objective in ''Healthy People 2020'' through ''increasing the proportion of persons with current asthma who receive appropriate asthma care according to the guidelines.'' 3 Concordance of health care delivery with quality measures has improved over time in patients with several disease conditions, such as heart failure, acute myocardial infarction, and pneumonia. [4] [5] [6] Compared with these emergency conditions, however, changes in the quality of emergency asthma care have attracted less attention. An analysis of survey data reported upward trends in the use of systemic corticosteroids and inhaled anticholinergic agents in the ED between 1993 and 2005. 7 However, their inferences are limited because of selection bias, potential errors in data collection and coding, and unmeasured confounders (eg, severity). Additionally, this study did not address important aspects of emergency asthma care (eg, assessment of airflow limitation and timeliness measures). Therefore it remains unclear whether the quality of emergency asthma care increased or decreased over time, particularly after the publication of the 2007 National Institutes of Health (NIH) guidelines.
To address this knowledge gap, we analyzed data from 3 multicenter observational studies of patients with asthma exacerbation; 2 studies were conducted during 1997-2001, and the third was conducted during 2011-2012. Our study objectives were3-fold: (1) to investigate changes in the concordance of asthma exacerbation management in the 48 EDs with recommendations in the NIH guidelines over these 16 years, (2) to identify ED characteristics associated with lower guideline concordance, and (3) to test whether higher concordance was associated with lower risk of hospitalization for asthma.
METHODS

Study design and setting
The present analysis combined data from 3 multicenter observational studies of adult ED patients with asthma exacerbation that were performed in 1997-2001 and 2011-2012 as part of the Multicenter Airway Research Collaboration (MARC).MARC is a part of the Emergency Medicine Network (EMNet), a collaboration of more than 225 EDs. 8 From 1997 to 2001, EMNet conducted 2 observational studies of adult ED patients with asthma exacerbations (the MARC-2 and MARC-5 studies). These studies consisted of ED interviews to assess patients' characteristics and chart reviews to assess ED presentation, asthma management, and disposition. The design, setting, and methods of data collection used in the studies have been reported previously. 9, 10 We recently completed the MARC-36 study, a multicenter chart review study that sought to characterize adult ED patients with asthma exacerbations and to determine the quality of their emergency care during 2011-2012. To better evaluate temporal changes in emergency asthma care, we recruited EDs by inviting the sites that had participated in the earlier MARC studies during 1997-2001. A total of 48 US EDs in 23 states completed the MARC-36 study (see Table  E1 and Fig E1 in 
Study participants
Using International Classification of Diseases, Ninth Revision, Clinical Modification, code 493.xx, 11 each site identified all visits with a primary ED or hospital discharge diagnosis of asthma during a 12-month period between January 1, 2011, and December 31, 2012 (ie, sites had a 24-month window from which to select the 12-month study period). Similar to the 1997-2001 studies, the inclusion criteria were ED visits made by adult patients aged 18 to 54 years and a history of physician-diagnosed asthma before the index ED visit. We excluded ED visits made by patients with a history of physician diagnosed chronic obstructive pulmonary disease, transfer ED visits, repeat ED visits, or ED visits not prompted largely by an asthma exacerbation. In the case of repeat visits, only the first randomly sampled ED visit was included. Therefore each ED visit in the study represented a unique ED patient.
Data measurements
In the MARC-36 study onsite chart reviewers at each site reviewed 40 ED charts that were randomly selected by the EMNet Coordinating Center at Massachusetts General Hospital. All reviewers participated in a 1-hour Web conference training session, and then reviewers completed 2 practice charts, which were evaluated with a ''criterion standard.'' If a reviewer's accuracy was less than 80% per chart, the reviewer was retrained.
ED-level covariates.
A key informant survey at each participating site was conducted to collect data on ED characteristics. Collected covariates included annual volume of ED visits, annual volume of asthma-related ED visits, affiliation with an emergency medicine residency program, urban-rural distinction, and region. Urban-rural distinctions were made according to the 2003 Urban Influences Codes. 12 Geographic regions were defined according to Census Bureau Boundaries.
Patient-level covariates.
In the MARC-36 study data abstraction was performed with a standardized form and included patients' demographics, past asthma history, current asthma medications, presentation, peak expiratory flow (PEF), asthma management in the ED or at discharge, and ED disposition. Severity of asthma exacerbation was classified according to the initial PEF at ED presentation as follows: mild, 400 L/min or greater for men and 300 L/min or greater for women; moderate, 250 to 399 L/min for men and 200 to 299 L/ min for women; severe, 150 to 249 L/min for men and 120 to 199 L/min for women; and very severe, less than 150 L/min for men and less than 120 L/ min for women.
14 This approach was used in earlier MARC studies. 9, 10, 15, 16 Quality measures Process measures. On the basis of common recommendations included in the 1997 and 2007 NIH guidelines [17] [18] [19] and using methods similar to those in the National Emergency Department Safety Study, 14 we derived a priori 9 explicit process measures. These process measures included 5 level A and 4 non-level A evidence-based measures (2 level B evidencebased treatments and 2 additional timeliness measures; see Table E2 in this article's Online Repository at www.jacionline.org).
We summarized these 9 evidence-based process measures by using a patient composite concordance score, which was computed as the sum of guideline-concordant care provided from the patient's total number of eligible opportunities. 20 These scores were then averaged across patients at the ED level to obtain ED composite scores.
14 These scores ranged from 0 to 100, with a score of 100 indicating perfect guideline concordance. 21 To assess whether the concordance varied by level of evidence, we calculated the scores for level A and non-level A guideline-recommended measures separately.
Outcome measures. The outcome of interest was hospitalization for asthma exacerbation, which was defined as hospital admission to an observation unit, inpatient unit, or intensive care unit (ICU).
Data analysis
Summary statistics at both the ED and patient levels were presented as means (with SDs), medians (with interquartile ranges [IQRs]), and proportions (with 95% CIs). At the patient level, the change in the item-by-item and overall concordance scores between the time periods were examined by using x2 tests or Wilcoxon-Mann-Whitney tests at the patient level. At the ED level, these changes were examined by using paired t tests to account for correlations within sites. Complete case analyses were used for these unadjusted analyses. Multiple imputation (using the multivariate normal model) was used for the multivariable regression analyses at both the ED and patient levels to account for the variables with significant missing data (see the Methods section in this article's Online Repository at www.jacionline.org). 22 ED-level analysis. Using the 2011-2012 data, we examined associations between ED characteristics and overall ED concordance scores by using multivariable linear regression, controlling for a predefined set of aggregate patient mix at the ED level (ie, age, sex, respiratory rate, oxygen saturation, and initial PEF at ED presentation). The missing values for the patientlevel characteristics were multiply imputed and then summarized for each ED (see the Methods section in this article's Online Repository). In the sensitivity analysis, to examine the robustness of the findings, we also generated the ED-level composite concordance scores by using opportunity-based methods. 21 Patient-level analysis. To examine the association of patients' composite concordance scores with the risk of hospitalization for asthma exacerbation in the 2011-2012 period, we constructed 2 regression models. First, we fitted an unadjusted model that included only the patient's composite score as the independent variable. Second, we fitted a 2-level mixed-effects model with binomial response by using random intercepts for EDs to account for the clustering of patients at the ED level. We adjusted for both patient-level variables (ie, age, sex, race/ethnicity, history of intubation for asthma, current use of systemic corticosteroids and inhaled corticosteroids, comorbidities, duration of symptoms, respiratory rate, oxygen saturation, and initial PEF at ED presentation) and ED-level variables (ie, annual ED visit volume, annual ED asthma volume, and region). For the models, only 4 level A evidence-based care treatments were used for computing the composite scores (ie, inhaled b-agonists, inhaled anticholinergic agents, and systemic corticosteroids and not receiving methylxanthines in the ED) to provide more weight to the treatments that have been shown to reduce asthma-related hospitalizations. 14, 19, 23, 24 The composite scores were treated as a dichotomous variable given the highly skewed distribution. Additionally, dichotomizing concordance into 100% concordance versus other concordance allowed us to examine how results differed using an all-or-none quality metric. 14, 25 In the sensitivity analysis, to address potential reverse causations in the association between guideline concordance and risk of hospitalization (ie, critically ill patients were hospitalized quickly before receiving all of the recommended care in the ED), we repeated the hospitalization model, excluding patients hospitalized within 1 hour of ED arrival or those admitted directly to the ICU. Additionally, to address the effect of patients with a prolonged ED length of stay, we also repeated the model using a different definition of the outcome (ie, hospitalization or ED length of stay >360 minutes). All tests were 2-tailed, and a P value of less than .05 was regarded as statistically significant. Multiple imputation was performed with Stata 12.0 software (StataCorp, College Station, Tex); other analyses were performed with SAS 9.3 software (SAS Institute, Cary, NC).
RESULTS
ED and patient characteristics
The analytic cohort comprised 4039 adult patients: 2119 patients from 1997-2001 versus 1920 patients from 2011-2012. All presented with an asthma exacerbation to one of the 48 participating EDs. Over these 16 years, participating EDs experienced a significant increase in annual volume of ED visits and a decrease in the number of asthma-related ED visits (both P < .01, Table I ). The proportion of EDs affiliated with an emergency medicine residency program increased during the time periods (P <.001). Participating EDs are all urban but located in different regions across the United States.
ED patients with asthma exacerbations in more recent years were younger and less likely to be female, of non-Hispanic white race, of Hispanic ethnicity, and current smokers (all P <.05, Table I ). Over the 2 time periods, chronic asthma burden decreased but remained high. For example, in the 2011-2012 period, 15% were hospitalized for asthma exacerbations in the past year, and 43% had visited the ED for asthma exacerbations. Likewise, use of long-term control medications increased over the time periods but remained underused in this population. For example, the proportion of asthmatic patients taking inhaled corticosteroids increased from 17% to 35% (P < .001). At ED presentation, according to the initial PEF results, 87% of patients were classified as having at least a moderate exacerbation in the 1997-2001 period and 80% in the 2011-2012 period (P < .001). After ED management, 21% of patients were hospitalized in the 1997-2001 period and 17% in the 2011-2012 period (P < .001). Table II summarizes the item-by-item guideline recommended management and overall concordance scores according to the time period. At the patient level, the median overall concordance score decreased from 80 (IQR, 67-89) in the 1997-2001 period to 75 (IQR, 57-86; P < .001) in the 2011-2012 period. This decrease was driven by significant decreases in concordance with the non-level A recommendations (ie, use of PEF assessment and timeliness measures) from a median score of 75 (IQR, 50-100) to 50 (IQR, 33-75). By contrast, the concordance with the level A recommendations improved, with significant increases in use of inhaled anticholinergic agents and systemic corticosteroids in the ED and in provision of an oral corticosteroid prescription at ED discharge (all P < .001).
Change in performance on quality measures
At the ED level, the overall concordance with the guideline recommendations also decreased, and its variation across EDs became larger over the 2 time periods, with a mean composite score of 75 (SD, 5) to 72 (SD, 8; P5.02). In the 2011-2012 period the best-performing ED had a score of 89, whereas the worst performing ED had a score of 59. Similar to the findings at the patient level, this decrease in overall score was driven by significant decreases in concordance with the non-level A recommendations (Fig 1) , such as PEF assessment (see Fig E2 in this article's Online Repository at www.jacionline.org) and timeliness measures (see Fig E3 in this article's Online Repository at www.jacionline.org), with larger variations in these measures across EDs (all P < .001). By contrast, the concordance with level A recommendations improved over these 16 years (Fig 2) . Table III shows ED characteristics associated with ED level guideline concordance in the 2011-2012 period. After adjusting for aggregated patient mix, Southern EDs and Western EDs were less likely to deliver guideline concordant care than Midwestern EDs. The sensitivity analysis using the opportunity-based method did not change the results materially.
ED characteristics and ED-level guideline Concordance
Patient-level guideline concordance and risk of hospitalization
In the 2011-2012 period, approximately 80% of patients received care perfectly concordant with the 4 level A recommendations (Table IV) . These patients had reduced risk of hospitalization compared with the others (14% vs 30%, P <.001). After adjusting for 14 patientand ED-level characteristics, risk of hospitalization remained significantly lower in patients who received fully concordant care in the ED (odds ratio, 0.37; 95% CI, 0.26-0.53; P < .001). Likewise, in sensitivity analyses the significant association persisted with excluding patients admitted within 1 hour of ED presentation or admitted to the ICU and with using a different definition for the outcome (ie, hospitalization or prolonged ED length of stay; Table IV) .
DISCUSSION
In this 48-center analysis based on 3 observational studies of 4039 adults with asthma exacerbation over 16 years, we observed changes in the quality of emergency asthma care that differed by level of guideline recommendation. Although emergency care became highly concordant with level A guideline recommendations, the concordance with non-level A recommendations (ie, use of PEF measurement and timeliness measures) decreased. Additionally, the variations in these measures became larger across the EDs, with significant regional differences. Our data also demonstrated a strong association between quality of care and patient outcomes. More specifically, complete concordance with the NIH asthma guidelines was associated with a significantly reduced risk of hospitalization.
The extent to which guideline-recommended asthma care is provided in the real-world setting is of great interest to a variety of stakeholders. However, to date, changes in the quality of emergency care for asthma exacerbations have attracted less attention. In the present study we found significant improvement in the concordance with guideline recommendations that are based on stronger evidence (eg, use of inhaled anticholinergic agents in the ED and systemic corticosteroids in the ED and at discharge). This observed improvement was consistent with the previous analysis of the National Hospital Ambulatory Medical Care Survey 7 and mirrored by the improvement in asthma care in the ambulatory 26 and pediatric inpatient 27 settings. Collectively, these findings reflect, at least in part, successful dissemination and implementation of the level A recommendations in the NIH guidelines over time.
The apparent improvement in concordance with level A recommendations contrasts sharply with the substantial decrease in concordance with the non-level A recommendations, with widening interhospital variations. In particular, we are struck by the decreasing use of PEF measurement in EDs over the study periods, although the NIH guidelines indicated that objective assessments of pulmonary function are central to asthma exacerbation diagnosis and risk stratification. 19 Additionally, we demonstrated prolonged or sustained delays in delivery of asthma care in the ED. Reasons for these decreases in concordance with non-level A recommendations need to be elucidated. For example, our data demonstrated a substantial increase in overall patient volumes in EDs over the 16 years; these findings are in agreement with the nationwide studies demonstrating increasing ED volumes. 28, 29 Additionally, prior studies have found an association between ED crowding and decreased quality of care. 30, 31 Therefore it is plausible that this system-wide factor might have contributed to the decrease in concordance with guideline recommendations that are based on weaker evidence. Our observations should facilitate further development of strategies for improving overcrowding in EDs. Furthermore, considering the successful implementation of the level A recommendations in the EDs, building more robust evidence on the non-level A recommendations (eg, PEF measurement and delivery of timely emergency asthma care), coupled with improved disseminations of these findings, could further improve care for ED patients with asthma exacerbations.
We were also struck by the wide variations in quality of emergency asthma care across the 48 EDs. The reasons for the observed practice variations are probably multifactorial. Our data identified that the variation in quality of care was partly explained by geographic region, even after adjusting for the other ED characteristics and patient mix, with Southern and Western EDs providing less guideline-concordant care than those in the Midwest. Parallel to these observations, the National Emergency Department Safety Study also showed a lower concordance with guideline recommendations in Southern EDs.14 However, the relationship between region and quality of emergency asthma care is complex. Geographic region is a surrogate marker for a number of patient, physician, institutional, and systems characteristics that affect quality of care but are difficult to quantify individually. We hope that our observations facilitate further investigation of any barriers to the delivery of high-quality asthma care in these underperforming EDs.
Process measures are designed to assess concordance with expected care and, when provided, should ''maximize health benefits to patients'' and lead to improved clinical outcomes (eg, reduced risk of hospitalization). 5, 32 In the present study we demonstrated that complete delivery of the guideline recommended asthma care (all or none) was associated with significantly lower risk of hospitalization. This association is encouraging and consistent with the results from our previous multicenter studies both in the United States and Japan. 14, 23 With multiple studies arriving at a similar conclusion, despite differing populations and health care settings, we believe that there is very robust evidence to support level A management in all EDs.
Taken together, many hospitalizations and the associated health care spending could be avoided if the variations in asthma care were attenuated and best practices were implemented in underperforming EDs. Use of an all-or-none metric certainly raises the bar on performance for providers, 14 and there might be potential resource disparities among sites that make it a challenge to implement some guideline recommendations. For patients with acute asthma, however, the level A recommendations are easily within reach (eg, prescribing systemic corticosteroids), and we believe that it is reasonable to expect a consistently high level of quality and performance in all US EDs. There is added urgency given that asthma is such a common public health problem. 23 Although improvement in the quality of emergency asthma care is ultimately the responsibility of the involved clinicians and hospitals, collective efforts with other stakeholders, such as community centers, professional organizations, and federal agencies, are warranted to overcome barriers to improving emergency asthma care nationally.
Potential limitations
Several study limitations should be noted. First, given the underuse of PEF measurement in this study, we might have underestimated the number of eligible patients who should receive anticholinergic agents or systemic corticosteroids in the ED. Accordingly, despite the high performance on these 2 measures, the smaller number of eligible patients using these measures carries less weight when calculating the overall concordance score, thereby underestimating the score.
Second, the study relied on medical record review for quality measure assessment; therefore some of the quality deficit might be due to underdocumentation. However, prior studies have demonstrated high agreement in ED asthma assessment and management between chart review and direct observation, with k coefficients ranging from 0.6 to 0.9. 33 Additionally, we used the identical approach to assess quality measures across studies, and this should mitigate any effect on the trend analysis.
Third, our study did not measure postdischarge care plans (eg, written discharge plans and follow-up care) and postdischarge outcomes (eg, revisits and readmissions). These important outcomes will be the focus of future research by the MARC investigators.
Fourth, as with any observational studies, the associations between higher concordance and lower risk of hospitalization does not necessarily prove causality and might by confounded by unmeasured factors, such as disease severity. However, we restricted the denominator of a quality measure to patients at risk for that measure to minimize potential confounding by severity and indication. 34 This approach has been used in prior studies of both acute and chronic asthma to adjust for this type of confounding. 14, [35] [36] [37] Lastly, our study population consisted of adults who presented mainly to academic EDs. Therefore our inferences might not be generalizable to children or asthma management in nonacademic EDs, where emergency asthma care might be better or worse than in our participating EDs. Nevertheless, we believe that our observations are highly relevant from a policy standpoint because these academic EDs train emergency medicine residents. Thus these institutions have a disproportionate effect on the quality of current and future emergency asthma care.
In summary, on the basis of observational studies of 4039 adults with asthma exacerbation in 48 US EDs, we found changes in quality of emergency asthma care that differed by level of guideline recommendation. The observed improvement in the concordance with level A guideline recommendations supports prior optimism that the quality of emergency asthma care can be improved and morbidity reduced. By contrast, the decreased concordance with non-level A recommendations and wide interhospital variations in quality of care present an important challenge. For researchers, these observations should facilitate further investigation to build more robust evidence on current non-level A recommendations. Finally, we found a strong association between fully concordant asthma care and reduced risk of hospitalization. Clinicians and policymakers will need to promote further adoption of level A recommendations and assist efforts to decrease the interhospital variations in quality of emergency asthma care to achieve better patient outcomes.
We thank the MARC-36 study hospitals and research personnel for their ongoing dedication to asthma research (see Table E1 and Fig E1 in this article' s Online Repository).
